PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer <i>in vitro</i> and <i>in vivo</i>-Reference-Cited by-同舟云学术

PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo

Published:2023-12-03 Issue: Volume: Page:1-13
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Deng Lili¹,Zhao Yan¹²,Liu Wen¹

Affiliation:

1. Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, China

2. Department of Radiology, Chongming Branch, Shanghai University of Medicine and Health Science, Shanghai, China

Funder

Shanghai Municipal Commission of Health

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2023.2288742

Reference27 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

3. Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice;Papanastasopoulos P;Anticancer Res,2014

4. METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma

5. Hallmarks of Cancer: New Dimensions

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM47 inhibits cisplatin chemosensitivity and endoplasmic reticulum stress-induced apoptosis of ovarian cancer cells;Molecular and Cellular Probes;2024-10